RA Capital Nexus Fund II, L.P.
Director, 10% Owner · Werewolf Therapeutics, Inc.
Every open-market stock purchase RA Capital Nexus Fund II, L.P. has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where how the prices paid compare to where the stock trades now.
Where the buys stand today
- HOWLWerewolf Therapeutics, Inc.
2 purchases totalling $435.3K at an average of $0.90 per share. See all insider buying in HOWL →
Avg price paid$0.90Latest price—Market capUnknown
All reported buys
Follow new qualifying clusters involving RA Capital Nexus Fund II, L.P. or other insiders
Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.
About this data
Figures are parsed from RA Capital Nexus Fund II, L.P.'s Form 4 filings on SEC EDGAR (CIK 1825376) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.
This page is informational and reflects public filing data. It is not investment advice.